Evidence map›Paper›PMID 41716493›Full record

ArticleFrontiers in nephrology2026

Beyond the resistive index: value of color-coded duplex sonography parameters in kidney transplantation.

Katharina Konzett, Sabrina Neururer, Martin Tiefenthaler

Abstract read
In one paragraph

Article in Frontiers in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katharina KonzettUniversity Hospital Internal Medicine IV (Nephrology and Hypertensiology), Innsbruck Medical University, Innsbruck, Austria.
Sabrina NeururerUniversity Hospital Internal Medicine IV (Nephrology and Hypertensiology), Innsbruck Medical University, Innsbruck, Austria.
Martin TiefenthalerUniversity Hospital Internal Medicine IV (Nephrology and Hypertensiology), Innsbruck Medical University, Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sonography is a key method in examining kidney transplants. Recent reports on the limited diagnostic value of an elevated resistive index (RI) in detecting rejection have cast doubt on the overall utility of color-coded duplex sonography (CCDS). This study evaluated additional CCDS parameters - percentage of vascularization (POV) and periphery vessel distance (PVD) - and investigated their association with histopathologic findings in allograft dysfunction. In a retrospective single-center study, 350 kidney transplant biopsies performed between 2013 and 2022 were analyzed. Standardized sonographic evaluation, including POV, PVD, and RI, was conducted at biopsy request. Histopathologic lesions were scored according to Banff criteria. Multivariable logistic regression identified independent predictors of abnormal CCDS parameters. Recipient age, severe tubular atrophy (ct), and arterial intimal fibrosis (cv) were independent negative predictors of POV > 50%. PVD ≥ 0.25 cm was associated with recipient age and moderate tubular atrophy (ct). RI showed no association with histopathologic lesions. These findings identify POV and PVD as non-invasive markers of chronic injury in kidney allografts, highlighting their potential adjunctive role in detecting parenchymal damage. As such, CCDS may support - but not replace - biopsy, which remains essential for establishing a definitive diagnosis in graft dysfunction.

Indexed as

Banff classificationcolor-coded duplexsonographykidney transplantationnon-invasive imaging biomarkersrenal allograft dysfunctionresistive index

Identifiers

PMID41716493
PMCPMC12913139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.